Beam Therapeutics vs Arrakis Bio
Beam Therapeutics vs Arrakis Bio, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Beam Therapeutics is on 47/100 and Arrakis Bio on 48/100.
Where each one leads
Beam Therapeutics
Leads on none of the measures we hold for both companies.
Arrakis Bio
- domain rating: 2/100 against 0/100
At a glance
| Measure | Beam Therapeutics | Arrakis Bio |
|---|---|---|
| What it is | A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases. | Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform. |
| Category | Workflows, Biotech, MedTech, Genomics | Life Sciences, Agritech, Food, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2019 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Beam Therapeutics | Arrakis Bio |
|---|---|---|
| Employees | Not published | 5 |
| Total funding | $235M | Not published |
| Latest round | Series C | Not published |
| LinkedIn followers | Not published | 850 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Beam Therapeutics | Arrakis Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 47/100 | 48/100 |
| Traction | 40/100 | 8/100 |
| Team | Not published | 30/100 |
| Search visibility | 2/100 | 34/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (43/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 2/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Beam Therapeutics | Arrakis Bio |
|---|---|---|
| CMS | Not detected | Wix |
| Open source | No | Yes |
Beam Therapeutics vs Arrakis Bio: common questions
Which is better, Beam Therapeutics or Arrakis Bio?
On our 0-100 score Arrakis Bio rates higher (48/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Beam Therapeutics and Arrakis Bio compare on the numbers?
Arrakis Bio leads on domain rating (2/100 against 0/100).
Read the full Beam Therapeutics review and pricing or the Arrakis Bio review and pricing. You can also browse other Beam Therapeutics alternatives we track.